| UniProt ID | RBBP7_HUMAN | |
|---|---|---|
| UniProt AC | Q16576 | |
| Protein Name | Histone-binding protein RBBP7 | |
| Gene Name | RBBP7 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 425 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Core histone-binding subunit that may target chromatin remodeling factors, histone acetyltransferases and histone deacetylases to their histone substrates in a manner that is regulated by nucleosomal DNA. Component of several complexes which regulate chromatin metabolism. These include the type B histone acetyltransferase (HAT) complex, which is required for chromatin assembly following DNA replication; the core histone deacetylase (HDAC) complex, which promotes histone deacetylation and consequent transcriptional repression; the nucleosome remodeling and histone deacetylase complex (the NuRD complex), which promotes transcriptional repression by histone deacetylation and nucleosome remodeling; and the PRC2/EED-EZH2 complex, which promotes repression of homeotic genes during development; and the NURF (nucleosome remodeling factor) complex.. | |
| Protein Sequence | MASKEMFEDTVEERVINEEYKIWKKNTPFLYDLVMTHALQWPSLTVQWLPEVTKPEGKDYALHWLVLGTHTSDEQNHLVVARVHIPNDDAQFDASHCDSDKGEFGGFGSVTGKIECEIKINHEGEVNRARYMPQNPHIIATKTPSSDVLVFDYTKHPAKPDPSGECNPDLRLRGHQKEGYGLSWNSNLSGHLLSASDDHTVCLWDINAGPKEGKIVDAKAIFTGHSAVVEDVAWHLLHESLFGSVADDQKLMIWDTRSNTTSKPSHLVDAHTAEVNCLSFNPYSEFILATGSADKTVALWDLRNLKLKLHTFESHKDEIFQVHWSPHNETILASSGTDRRLNVWDLSKIGEEQSAEDAEDGPPELLFIHGGHTAKISDFSWNPNEPWVICSVSEDNIMQIWQMAENIYNDEESDVTTSELEGQGS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 (in isoform 2) | Acetylation | - | 29.34 | 20068231 | |
| 2 | Acetylation | ------MASKEMFED ------CCCHHHHHH | 29.34 | 22814378 | |
| 3 | Phosphorylation | -----MASKEMFEDT -----CCCHHHHHHH | 28.05 | 29255136 | |
| 4 | Sumoylation | ----MASKEMFEDTV ----CCCHHHHHHHH | 43.59 | - | |
| 4 | 2-Hydroxyisobutyrylation | ----MASKEMFEDTV ----CCCHHHHHHHH | 43.59 | - | |
| 4 | Sumoylation | ----MASKEMFEDTV ----CCCHHHHHHHH | 43.59 | 28112733 | |
| 4 | Acetylation | ----MASKEMFEDTV ----CCCHHHHHHHH | 43.59 | 19608861 | |
| 4 | Ubiquitination | ----MASKEMFEDTV ----CCCHHHHHHHH | 43.59 | 19608861 | |
| 6 | Sulfoxidation | --MASKEMFEDTVEE --CCCHHHHHHHHHH | 5.25 | 21406390 | |
| 10 | Phosphorylation | SKEMFEDTVEERVIN CHHHHHHHHHHHHHC | 23.71 | 21712546 | |
| 13 (in isoform 2) | Phosphorylation | - | 48.16 | 30108239 | |
| 14 | Methylation | FEDTVEERVINEEYK HHHHHHHHHHCHHHH | 22.55 | 115490439 | |
| 20 | Phosphorylation | ERVINEEYKIWKKNT HHHHCHHHHHHHCCC | 11.12 | 25106551 | |
| 21 | Sumoylation | RVINEEYKIWKKNTP HHHCHHHHHHHCCCH | 45.42 | - | |
| 21 | Acetylation | RVINEEYKIWKKNTP HHHCHHHHHHHCCCH | 45.42 | 22636321 | |
| 21 | Ubiquitination | RVINEEYKIWKKNTP HHHCHHHHHHHCCCH | 45.42 | 21890473 | |
| 21 | Sumoylation | RVINEEYKIWKKNTP HHHCHHHHHHHCCCH | 45.42 | - | |
| 24 | Ubiquitination | NEEYKIWKKNTPFLY CHHHHHHHCCCHHHH | 39.35 | 21890473 | |
| 25 | Ubiquitination | EEYKIWKKNTPFLYD HHHHHHHCCCHHHHH | 51.57 | - | |
| 27 | Phosphorylation | YKIWKKNTPFLYDLV HHHHHCCCHHHHHHH | 25.05 | 30177828 | |
| 31 | Phosphorylation | KKNTPFLYDLVMTHA HCCCHHHHHHHHHHH | 13.96 | 30177828 | |
| 36 | Phosphorylation | FLYDLVMTHALQWPS HHHHHHHHHHHHCCC | 9.12 | 30177828 | |
| 60 | Phosphorylation | TKPEGKDYALHWLVL CCCCCCCEEEEEEEE | 17.97 | 28152594 | |
| 65 | Ubiquitination | KDYALHWLVLGTHTS CCEEEEEEEEECCCC | 1.26 | 21890473 | |
| 68 | Ubiquitination | ALHWLVLGTHTSDEQ EEEEEEEECCCCCCC | 14.15 | 21890473 | |
| 95 | Phosphorylation | DDAQFDASHCDSDKG CCCCCCHHHCCCCCC | 26.88 | 23401153 | |
| 99 | Phosphorylation | FDASHCDSDKGEFGG CCHHHCCCCCCCCCC | 46.76 | 29255136 | |
| 101 | Ubiquitination | ASHCDSDKGEFGGFG HHHCCCCCCCCCCCC | 65.38 | - | |
| 101 | 2-Hydroxyisobutyrylation | ASHCDSDKGEFGGFG HHHCCCCCCCCCCCC | 65.38 | - | |
| 101 | Acetylation | ASHCDSDKGEFGGFG HHHCCCCCCCCCCCC | 65.38 | 23749302 | |
| 109 | Phosphorylation | GEFGGFGSVTGKIEC CCCCCCCEECEEEEE | 17.78 | 24732914 | |
| 111 | Phosphorylation | FGGFGSVTGKIECEI CCCCCEECEEEEEEE | 34.16 | 24732914 | |
| 113 | Sumoylation | GFGSVTGKIECEIKI CCCEECEEEEEEEEE | 26.43 | - | |
| 113 | Acetylation | GFGSVTGKIECEIKI CCCEECEEEEEEEEE | 26.43 | 26051181 | |
| 113 | Ubiquitination | GFGSVTGKIECEIKI CCCEECEEEEEEEEE | 26.43 | - | |
| 119 | Sumoylation | GKIECEIKINHEGEV EEEEEEEEECCCCCC | 18.37 | - | |
| 119 | Acetylation | GKIECEIKINHEGEV EEEEEEEEECCCCCC | 18.37 | 16916647 | |
| 119 | 2-Hydroxyisobutyrylation | GKIECEIKINHEGEV EEEEEEEEECCCCCC | 18.37 | - | |
| 119 | Sumoylation | GKIECEIKINHEGEV EEEEEEEEECCCCCC | 18.37 | - | |
| 119 | Ubiquitination | GKIECEIKINHEGEV EEEEEEEEECCCCCC | 18.37 | - | |
| 119 | Malonylation | GKIECEIKINHEGEV EEEEEEEEECCCCCC | 18.37 | 26320211 | |
| 130 | Methylation | EGEVNRARYMPQNPH CCCCCCEEECCCCCC | 25.66 | 115490431 | |
| 142 | Ubiquitination | NPHIIATKTPSSDVL CCCEEEECCCCCCEE | 49.79 | 21890473 | |
| 143 | Phosphorylation | PHIIATKTPSSDVLV CCEEEECCCCCCEEE | 24.85 | 30266825 | |
| 145 | Phosphorylation | IIATKTPSSDVLVFD EEEECCCCCCEEEEE | 44.39 | 30266825 | |
| 146 | Phosphorylation | IATKTPSSDVLVFDY EEECCCCCCEEEEEC | 32.70 | 30266825 | |
| 153 | Phosphorylation | SDVLVFDYTKHPAKP CCEEEEECCCCCCCC | 13.26 | 28152594 | |
| 154 | Phosphorylation | DVLVFDYTKHPAKPD CEEEEECCCCCCCCC | 25.40 | 28152594 | |
| 155 | Acetylation | VLVFDYTKHPAKPDP EEEEECCCCCCCCCC | 41.17 | 25953088 | |
| 155 | Sumoylation | VLVFDYTKHPAKPDP EEEEECCCCCCCCCC | 41.17 | 28112733 | |
| 155 | Ubiquitination | VLVFDYTKHPAKPDP EEEEECCCCCCCCCC | 41.17 | - | |
| 159 | Methylation | DYTKHPAKPDPSGEC ECCCCCCCCCCCCCC | 55.17 | 23644510 | |
| 159 | Sumoylation | DYTKHPAKPDPSGEC ECCCCCCCCCCCCCC | 55.17 | - | |
| 159 | Acetylation | DYTKHPAKPDPSGEC ECCCCCCCCCCCCCC | 55.17 | 23749302 | |
| 159 | Ubiquitination | DYTKHPAKPDPSGEC ECCCCCCCCCCCCCC | 55.17 | - | |
| 159 | Sumoylation | DYTKHPAKPDPSGEC ECCCCCCCCCCCCCC | 55.17 | 28112733 | |
| 177 | Ubiquitination | LRLRGHQKEGYGLSW CCCCCCCCCCCCCCC | 47.64 | - | |
| 186 | Ubiquitination | GYGLSWNSNLSGHLL CCCCCCCCCCCCEEE | 32.65 | 21890473 | |
| 214 | Acetylation | NAGPKEGKIVDAKAI CCCCCCCCEEECEEE | 40.42 | 26051181 | |
| 214 | Ubiquitination | NAGPKEGKIVDAKAI CCCCCCCCEEECEEE | 40.42 | - | |
| 219 | Ubiquitination | EGKIVDAKAIFTGHS CCCEEECEEEEECCC | 37.24 | - | |
| 257 | Methylation | KLMIWDTRSNTTSKP CEEEEECCCCCCCCC | 25.99 | - | |
| 263 | Ubiquitination | TRSNTTSKPSHLVDA CCCCCCCCCHHEEEC | 48.74 | - | |
| 263 | Acetylation | TRSNTTSKPSHLVDA CCCCCCCCCHHEEEC | 48.74 | 26051181 | |
| 296 | Phosphorylation | ATGSADKTVALWDLR ECCCCCCEEEEEEHH | 16.14 | 21712546 | |
| 303 | Methylation | TVALWDLRNLKLKLH EEEEEEHHCCEEEEE | 43.92 | - | |
| 306 | Sumoylation | LWDLRNLKLKLHTFE EEEHHCCEEEEEEEC | 47.31 | - | |
| 308 | 2-Hydroxyisobutyrylation | DLRNLKLKLHTFESH EHHCCEEEEEEECHH | 36.31 | - | |
| 308 | Ubiquitination | DLRNLKLKLHTFESH EHHCCEEEEEEECHH | 36.31 | - | |
| 314 | Phosphorylation | LKLHTFESHKDEIFQ EEEEEECHHCCCEEE | 31.48 | - | |
| 316 | Ubiquitination | LHTFESHKDEIFQVH EEEECHHCCCEEEEE | 67.35 | 21906983 | |
| 325 | Phosphorylation | EIFQVHWSPHNETIL CEEEEEECCCCCEEE | 11.03 | 26714015 | |
| 340 | Methylation | ASSGTDRRLNVWDLS CCCCCCCCCEEEEHH | 33.16 | - | |
| 347 | Phosphorylation | RLNVWDLSKIGEEQS CCEEEEHHHHCCCCC | 21.54 | 21815630 | |
| 348 | Ubiquitination | LNVWDLSKIGEEQSA CEEEEHHHHCCCCCH | 63.13 | 2190698 | |
| 354 | Phosphorylation | SKIGEEQSAEDAEDG HHHCCCCCHHHCCCC | 36.58 | 30266825 | |
| 360 | Ubiquitination | QSAEDAEDGPPELLF CCHHHCCCCCCEEEE | 76.30 | 21890473 | |
| 373 | Phosphorylation | LFIHGGHTAKISDFS EEEECCCEEEECCCC | 32.68 | 23403867 | |
| 377 | Phosphorylation | GGHTAKISDFSWNPN CCCEEEECCCCCCCC | 31.71 | 20068231 | |
| 380 | Phosphorylation | TAKISDFSWNPNEPW EEEECCCCCCCCCCE | 30.82 | 20068231 | |
| 391 | Phosphorylation | NEPWVICSVSEDNIM CCCEEEEEECHHHHH | 19.97 | 20068231 | |
| 393 | Phosphorylation | PWVICSVSEDNIMQI CEEEEEECHHHHHHH | 23.96 | 20068231 | |
| 408 | Phosphorylation | WQMAENIYNDEESDV HHHHHHHCCCCCCCC | 28.30 | 20068231 | |
| 413 | Phosphorylation | NIYNDEESDVTTSEL HHCCCCCCCCCHHHH | 35.02 | 20068231 | |
| 416 | Phosphorylation | NDEESDVTTSELEGQ CCCCCCCCHHHHCCC | 29.60 | 20068231 | |
| 417 | Phosphorylation | DEESDVTTSELEGQG CCCCCCCHHHHCCCC | 21.76 | 20068231 | |
| 418 | Phosphorylation | EESDVTTSELEGQGS CCCCCCHHHHCCCCC | 30.71 | 20068231 | |
| 425 | Phosphorylation | SELEGQGS------- HHHCCCCC------- | 29.21 | 20068231 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 314 | S | Phosphorylation | Kinase | AMPKA1 | Q13131 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RBBP7_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RBBP7_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| "Quantitative analysis of global ubiquitination in HeLa cells by massspectrometry."; Meierhofer D., Wang X., Huang L., Kaiser P.; J. Proteome Res. 7:4566-4576(2008). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, UBIQUITINATION [LARGESCALE ANALYSIS] AT LYS-4, AND MASS SPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-413 AND THR-416,ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-4 AND LYS-21, AND MASSSPECTROMETRY. | |
| "Substrate and functional diversity of lysine acetylation revealed bya proteomics survey."; Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.; Mol. Cell 23:607-618(2006). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-119, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-354, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-354, AND MASSSPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-413 AND THR-416,ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-413 AND THR-416, ANDMASS SPECTROMETRY. | |
| Ubiquitylation | |
| Reference | PubMed |
| "Quantitative analysis of global ubiquitination in HeLa cells by massspectrometry."; Meierhofer D., Wang X., Huang L., Kaiser P.; J. Proteome Res. 7:4566-4576(2008). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, UBIQUITINATION [LARGESCALE ANALYSIS] AT LYS-4, AND MASS SPECTROMETRY. | |